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ABSTRACT
Background: Sepsis remains a leading cause of death in 
intensive care units. There is growing evidence that volatile 
anesthetics have beneficial immunomodulatory effects on 
complex inflammation-mediated conditions. The authors 
investigated the effect of volatile anesthetics on the overall 
survival of mice in a sepsis model of cecal ligation and punc-
ture (CLP).
Methods: Mice (N = 12 per treatment group) were exposed 
to anesthetic concentrations of desflurane, isoflurane, and 
sevoflurane either during induction of sepsis or when the 
mice showed pronounced symptoms of inflammation. 
Overall survival, as well as organ function and inflammation 
was compared with the CLP group without intervention.
Results: With desflurane and sevoflurane conditioning (1.2 
minimal alveolar concentration for 2 h immediately after 
induction of CLP) overall survival was improved to 58% 
and 83%, respectively, compared with 17% in the untreated 
CLP group. Isoflurane did not significantly affect outcome. 
Application of sevoflurane 24 h after sepsis induction signifi-
cantly improved overall survival to 66%.
Conclusions: Administration of the volatile anesthetics 
desflurane and sevoflurane reduced CLP-induced mortal-
ity. Anesthesia may be a critical confounder when compar-
ing study data where different anesthesia protocols were 
used.
S EPSIS and septic shock remain the leading causes of death in intensive care units worldwide.1 Com-
plex pathophysiology together with heterogeneous disease 
patterns are key features making the treatment of sepsis 
extremely challenging.2–5 Numerous approaches have been 
undertaken to attenuate the harmful host response to infec-
tion, with a mostly unsuccessful translation into clinical out-
come. Despite new pathophysiological insights and major 
efforts in developing goal-directed therapies, mortality in 
septic patients remains considerably high, and the treatment 
of late stage diagnosed patients is generally associated with 
bad outcome.6
Volatile anesthetics such as desflurane, isoflurane, and 
sevoflurane have been identified as effective modifiers of 
the inflammatory response in various states of tissue injury, 
exerting beneficial effects on organ function and overall 
What We Already Know about This Topic
•	 Volatile	anesthetics	have	been	shown	to	be	antiinflammatory	
agents	in	certain	conditions
What This Article Tells Us That Is New
•	 Exposing	septic	mice	to	volatile	anesthetics,	particularly	sevo-
flurane,	significantly	improved	survival
◆	 This	article	is	accompanied	by	an	Editorial	View.	Please	see:	
Kharasch	ED,	Coopersmith	CM:	Sleeping	to	survive?	The	impact	
of	volatile	anesthetics	on	mortality	 in	sepsis.	AnESThESiology		
2013;	119:755–6.Copyright © 2013, the American Society of Anesthesiologists, Inc. Lippincott 
Williams & Wilkins. Anesthesiology 2013; 119:901-6
* Research Associate, Institute of Anesthesiology, University Hos-
pital Zurich and Institute of Physiology and Zurich Centre for Inte-
grative Human Physiology, University of Zurich, Zurich, Switzerland. 
† Research Assistant, Department of Anesthesiology, University of 
Illinois College of Medicine at Chicago, Chicago, Illinois, and Depart-
ment of Pharmacology, University of Illinois at Chicago, Chicago, 
Illinois. ‡ Full Professor, Department of Anesthesiology, University 
of Illinois College of Medicine at Chicago. § Technician, Institute of 
Anesthesiology, University Hospital Zurich and Institute of Physiol-
ogy and Zurich Centre for Integrative Human Physiology, University 
of Zurich. ║Research Associate, Institute of Anesthesiology, Univer-
sity Hospital Zurich and Institute of Physiology and Zurich Centre 
for Integrative Human Physiology, University of Zurich. # Associate 
Professor, Department of Anesthesiology, University of Illinois Col-
lege of Medicine at Chicago, and Department of Pharmacology, Uni-
versity of Illinois at Chicago. ** Associate Professor, Department of 
Anesthesiology, University of Illinois College of Medicine at Chicago, 
and Department of Pharmacology, University of Illinois at Chicago. 
†† Full Professor, Institute of Anesthesiology, University Hospital 
Zurich and Institute of Physiology and Zurich Centre for Integrative 
Human Physiology, University of Zurich.
Received from the Institute of Anesthesiology, University Hos-
pital Zurich and the Institute of Physiology and Centre for Integra-
tive Human Physiology, University of Zurich, Zurich, Switzerland. 
Submitted for publication January 20, 2012. Accepted for publica-
tion March 28, 2013. Support was provided by the National Insti-
tutes of Health, Bethesda, Maryland, grant nos. NIH P01 HL60678 
and R01 HL71626; Emdo Foundation, Zurich, Switzerland; and 
Swiss National Science Foundation, Berne, Switzerland, grant 
no. 320030_141216. Dr. Herrmann and Ms. Castellon contributed 
equally as first authors. Drs. Minshall and Beck-Schimmer contrib-
uted equally as senior authors.
Address correspondence to Dr. Beck-Schimmer: Institute of 
Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 
Zurich, Switzerland. beatrice.beckschimmer@uzh.ch. Information on 
purchasing reprints may be found at www.anesthesiology.org or on 
the masthead page at the beginning of this issue. ANESTHESIoLogy’s 
articles are made freely accessible to all readers, for personal use 
only, 6 months from the cover date of the issue.
Volatile Anesthetics Improve Survival after Cecal 
Ligation and Puncture
inge	K.	herrmann,	Ph.D.,*	Maricela	Castellon,	M.S.,†	David	E.	Schwartz,	M.D.,‡	Melanie	hasler,§	
Martin	Urner,	M.D.,║	guochang	hu,	M.D.,	Ph.D.,#	Richard	D.	Minshall,	Ph.D.,**		
Beatrice	Beck-Schimmer,	M.D.††
Anesthesiology 2013; 119:901-6 902 Herrmann et al.
Immunomodulation by Volatile Anesthetics
outcome in both animals7–12 and patients.13–16 Potential 
benefits of the application of volatile anesthetics in in vivo 
models of experimental sepsis have not been systematically 
explored, and their effect on survival remains unclear. Pre-
vious studies elucidating the protective potential of volatile 
anesthetics have traditionally focused on ischemia–reper-
fusion injury and not on sepsis. In addition, biomarkers 
of organ injury were determined, but outcome parameters 
were not.17
In this study, we investigated in a model of severe murine 
sepsis with intraabdominal focus (peritonitis) whether 
the volatile anesthetics desflurane, isoflurane, and sevo-
flurane impact on overall survival of septic animals. The 
cecal ligation and puncture (CLP) model is considered the 
“gold standard” in sepsis research with a disease profile 
similar to that in human sepsis in that it encompasses more 
of the clinical features and drug responses of human sep-
sis, than, for example, the lipopolysaccharide model,18,19 
despite the absence of some key features (e.g., kidney and 
lung injury). In this study, mice were exposed to desflu-
rane, isoflurane, or sevoflurane during induction of sepsis 
(conditioning). To investigate the effect in a postcondi-
tioning setting, desflurane and sevoflurane were applied 
24 h after the CLP procedure, when the mice showed 
pronounced symptoms of inflammation. Survival as well 
as markers of renal and hepatic organ function was com-
pared with the CLP group without intervention. Being 
aware of the limitations of animal models of sepsis, the 
current study illustrates the beneficial effects of the volatile 
anesthetics desflurane and sevoflurane in states of severe 
inflammation leading to a remarkably improved 7-day sur-
vival and reduced end-organ damage.
Materials and Methods
Animals
The animal protocol was approved by the University of Illi-
nois Animal Care and Use Committee (Chicago, Illinois). 
All experiments were performed in accordance with Associa-
tion for Assessment and Accreditation of Laboratory Ani-
mal Care guidelines as defined by the National Institutes of 
Health and the Guide for the Care and Use of Laboratory Ani-
mals. Eight- to 12-week-old male C57BL/6 mice (Charles 
River Laboratories, Chicago, IL) with body weights between 
22 and 31 g (25.8 ± 2.7 g) were used for the experiments. 
The animals were closely monitored before and during the 
experiments, assessing respiration, health (fur, teeth, and 
body weight), and signs of pain or distress. All mice received 
buprenorphine (0.1 mg/kg subcutaneously) immediately 
after surgery and as needed thereafter for analgesia. Severely 
moribund mice were euthanized by anesthetic overdose fol-
lowed by cervical dislocation.
Anesthesia and Sepsis Induction by CLP
CLP Procedure. The CLP procedure was carried out at the 
same time of the day to account for circadian rhythm effects 
on the inflammatory response. Mice were anesthetized using 
a single dose of ketamine (100 mg/kg body weight; Fort 
Dodge Laboratories, Fort Dodge, IA) and xylazine (10 mg/
kg body weight; Ben Venue Lab, Bedford, OH), applied 
intraperitoneally unless otherwise stated. CLP was carried 
out as described by Rittirsch et al.18 In brief, once a surgical 
plane of anesthesia was reached, as determined by the lack 
of response to paw or tail pinch and eye reflex, the abdomen 
was shaved, cleaned, and de-germed using a povidone-iodine 
solution before a 1-cm midline incision was made. The 
cecum was exposed and the distal 20% (below the ileoce-
cal valve, approximately 1 cm from the tip) was ligated with 
a 6-0 suture. The cecum was punctured four times with a 
20-gauge needle. When returning the cecum into the abdo-
men, a well-controlled, small amount of feces was extruded 
from mesenteric and antimesenteric penetration holes. The 
wound was cleaned with 0.5 ml of sterile saline, and the 
peritoneal cavity was closed in two layers with 7-0 and 6-0 
prolene sutures, respectively. SHAM animals underwent the 
same procedure without ligation and puncture of the cecum.
Treatment Groups. Desflurane, isoflurane, and sevoflurane 
conditioning mice (N = 12 for each group) were anesthetized 
with 1.2 minimal alveolar concentration (MAC) of desflu-
rane (9 vol%)20 (Baxter Healthcare Corporation, Deerfield, 
IL), isoflurane (1.5 vol%)20 (Piramal Critical Care, Inc., 
Bethlehem, PA), or sevoflurane (4 vol%)20 (Baxter Health-
care Corporation) via nose-cone, respectively (instead of 
ketamine/xylazine). After CLP and injection of saline (20 
ml·kg−1·h−1) through the jugular vein, mice were allowed to 
spontaneously breathe desflurane, isoflurane, or sevoflurane 
(1.2 MAC) for an additional 2 h. In the sevoflurane post-
conditioning group, CLP-induced injury was performed 
under ketamine/xylazine anesthesia. Sevoflurane was admin-
istered 24 h after CLP (either 1.2 MAC for 2 h, N = 8, or at 
a reduced dose of 1 MAC for a duration of 0.5 h, N = 12). 
For desflurane postconditioning, 1 MAC of desflurane was 
administered 24 h after CLP for 0.5 h. All animals were 
closely monitored, and the depth and duration of anesthesia 
was comparable for all groups included in the experiment.
Survival Studies
For survival studies, mice were returned to their cages after 
CLP induction and closely monitored for up to 7 days. Mice 
were given ad libitum access to food and water at all times.
Analysis of Blood and Tissue Samples 24 h after Sepsis 
Induction
In the next series of experiments, samples were harvested 24 h 
after CLP induction and animals were euthanized immedi-
ately after (N = 6). Peritoneal lavage and blood samples were 
collected to quantitatively assess markers of disease severity, 
end-organ damage, and bacterial load. Twenty-four hours 
after induction of CLP, mice were anesthetized with ketamine/
xylazine and 2 ml of sterile 0.9% NaCl was instilled into the 
peritoneal cavity. The abdomen was massaged gently for 1 min 
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and then opened with sterile scissors. Recovered peritoneal 
lavage (1–1.5 ml) was used for cytokine analysis and bacterial 
count. For detection of cytokines, peritoneal fluid was cen-
trifuged at 2,500 rpm for 10 min at 4°C, and the supernatant 
was stored at −80°C. For blood sampling after 24 h of injury, 
50 µl of heparin (1,000 units/ml) was injected into the infe-
rior vena cava and allowed to circulate for 1 min before eutha-
nizing the animals. Using an angiocath (20-gauge), 500–700 
µl of blood was collected. Markers of renal and hepatic organ 
function (blood urea nitrogen, alkaline phosphatase, alanine 
transaminase, and aspartate transaminase), total protein, and 
albumin levels were analyzed in fresh plasma samples with a 
Hitachi 916 chemistry analyzer (Roche Diagnostics, Laval, 
Quebec, Canada). For bacterial load determination, perito-
neal fluid and blood were serially diluted in sterile saline, and 
10 µl of the diluted samples were plated immediately after 
sample collection on tryptic blood agar plates. After incuba-
tion at 37°C for 20 h, bacterial colony forming units were 
counted. Cytokine concentrations were measured in both 
plasma and peritoneal fluid using enzyme-linked immunosor-
bent assay (ELISA) kits for mouse monocyte chemoattractant 
protein-1 and interleukin-6 (both from BD Biosciences, San 
Diego, CA). Procedures were carried out according to the pro-
tocol provided by the manufacturer.
Statistical Analysis
Sample sizes were determined based on previous studies.9 
Survival data were analyzed using Origin (Kaplan–Meier 
Survival Analysis; OriginLAB, Northampton, MA). Log 
rank test with Bonferroni correction was used to compare 
survival distributions. Bar graphs show means ± SD. Mark-
ers for organ function and levels of inflammatory mediators 
for treated and untreated groups were compared using Krus-
kal–Wallis ANOVA with Mann–Whitney U tests (small 
sample size, two-tailed) and Bonferroni correction for mul-
tiple comparisons. Power analysis was calculated using SPSS 
version 20.0 (IBM, Zurich, Switzerland). Statistical signifi-
cance was assigned to a P value of less than 0.05.
Results
Mortality rate in the CLP group was 75% within the first 48 h. 
One day after induction of CLP, mice showed pronounced 
symptoms of severe sepsis, including reduced mobility, starry 
fur, hunched appearance, lethargy, and weight loss (>10%). 
The overall survival in the CLP group after 7 days was 17%. 
However, when mice were exposed to 1.2 MAC desflurane 
during and for additional 2 h after surgery, overall survival 
increased to 58% (P = 0.049; N = 12; fig. 1A). Similarly, 
when mice were exposed to 1.2 MAC (4 vol%) sevoflurane, 
they showed significant improvement in overall survival 
(83%) compared with the CLP group (P < 0.001; N = 12) 
(fig. 1A). Symptoms of sepsis were less pronounced during 
the entire observation period and mice regained full mobility 
with body weight increasing by day 3 after CLP induction. 
Exposing mice to equi-MACs of isoflurane (1.2 MAC, 2 h) 
was less effective and did not significantly improve overall 
survival compared with the CLP group without condition-
ing (42% survival; P = 0.12; N = 12; fig. 1A). Only at the 
48-h time point was a significant difference observed in the 
isoflurane group compared with the CLP group (75% sur-
vival compared with 50%; P = 0.042).
Based on the promising results observed in the desflu-
rane and the sevoflurane conditioning groups, the adminis-
tration of volatile anesthetics during sepsis was investigated 
in a postconditioning setting: 24 h after induction of CLP, 
desflurane or sevoflurane was applied to mice suffering from 
severe sepsis with pronounced symptoms. When expos-
ing mice to 1.2 MAC sevoflurane for 2 h, however, a large 
number died either during or within the first few hours after 
anesthesia. Overall survival was not different from the CLP 
group without intervention (fig. 1B). Reducing the sevoflu-
rane dose (from 1.2 to 1 MAC) and exposure time (from 
2 to 0.5 h) significantly improved overall survival to 66% 
(P = 0.045). In this group, no deaths were observed after 
postoperative day 2. Desflurane postconditioning (1 MAC, 
0.5 h) did not significantly improve outcome (fig. 1B).
Seven days after CLP, all surviving mice developed abscesses 
in the region of the cecum. Considering that the primary 
Fig. 1. Survival analyses—volatile anesthetics. (A) Conditioning 
with volatile anesthetics. Survival was assessed over 7 days in 
a cecal ligation and puncture (CLP) model with a >75% mortal-
ity at postoperative day 3 and overall survival of 17% observed 
in the CLP group. Exposure (1.2 MAC for 2 h) to anesthetic 
concentrations of desflurane and sevoflurane significantly im-
proved overall survival in CLP mice to 58% (P = 0.049) and 83% 
(P < 0.001), respectively. Equi-MAC concentrations of isoflurane 
were less effective (P = 0.12). (B) Postconditioning with volatile 
anesthetics. Sevoflurane but not desflurane postconditioning 
(1 MAC for 0.5 h) 24 h after CLP procedure markedly improved 
overall survival of 66% no mortality after postoperative day 2 
(P = 0.045). DES = desflurane; ISO = isoflurane; MAC = minimal 
alveolar concentration; Postcond = postconditioning; SEVO = 
sevoflurane. *P < 0.05.
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objective of the host response to bacterial infection is removal 
of the organisms, bacterial numbers in the peritoneum and 
blood were counted. No significant differences regarding bac-
terial load were found either in peritoneal fluid samples or 
blood samples collected at 24 h after CLP versus CLP + sevo-
flurane (peritoneal fluid, 2.00 [±1.71] × 107 colony forming 
units/ml for CLP [N = 6] vs. 2.54 [±0.79] × 107 colony form-
ing units/ml for CLP + sevoflurane (N = 6), no bacteria were 
detected in samples from SHAM animals [N = 4]).
The measurement of biochemical parameters of tis-
sue injury in SHAM, CLP, and CLP + sevoflurane ani-
mals revealed that sevoflurane significantly attenuated 
CLP-induced kidney and liver injury. Assessing markers 
for renal function 24 h after CLP, increased levels of blood 
urea nitrogen were found in the CLP group. Condition-
ing with sevoflurane significantly decreased plasma lev-
els of blood urea nitrogen (P = 0.049; fig. 2A). Increased 
plasma levels of alanine transaminase and aspartate trans-
aminase were measured for the CLP group compared with 
the SHAM group. In mice with sevoflurane conditioning, 
alanine transaminase and aspartate transaminase levels 
were significantly lower (alkaline phosphatase: P = 0.462; 
alanine transaminase: P = 0.009; aspartate transaminase: 
P = 0.002; N = 6; fig. 2B). Total plasma protein and albumin 
levels were comparable for all groups. Plasma and peritoneal 
fluid cytokine levels are illustrated in figure 3. CLP induced 
high levels of cytokines in both plasma and peritoneal fluid 
with significant increases in CLP compared to SHAM ani-
mals in the peritoneal fluid only (interleukin-6: P < 0.05; 
monocyte chemoattractant protein-1: P < 0.05).
Discussion
The major findings of this study are that application of the 
volatile anesthetic sevoflurane significantly improved over-
all survival in a murine model of septic peritonitis when 
administered during the surgical procedure as well as 24 h 
after induction of CLP. Similarly, desflurane but not isoflu-
rane positively affected survival in a conditioning setting. 
Fig. 2. Renal (A) and hepatic (B) function in SHAM, cecal 
ligation and puncture (CLP), and sevoflurane cocondition-
ing groups. Assessing renal injury markers, a CLP-induced 
increase in blood urea nitrogen (BUN) was found. Hepatic 
markers (alkaline phosphatase [ALP]; alanine transaminase 
[ALT]; aspartate transaminase [AST]) were increased in the 
CLP group (N = 6) compared with the SHAM group (N = 3). 
Compared with the CLP group, application of sevoflurane 
(SEVO, 1.2 minimal alveolar concentration, 2 h, N = 6) in CLP 
animals efficiently reduced markers of organ damage to levels 
that were comparable with those in SHAM animals. Values 
are means ± SD. *P < 0.05. SEVO = sevoflurane.
Fig. 3. Cytokines—markers of inflammation. Inflamma-
tory mediator levels in blood and peritoneal fluid 24 h af-
ter cecal ligation and puncture (CLP) induction. A CLP-
induced increase in interleukin-6 (IL-6) (A) and monocyte 
chemoattractant protein-1 (MCP-1) (B) was found in 
plasma and peritoneal fluid from CLP mice (N = 6) com-
pared with SHAM animals (N = 3). The inflammatory me-
diator release was not significantly altered by application 
of sevoflurane (1.2 minimum alveolar concentration, 2 h, 
N = 6) in CLP animals. Values are means ± SD. *P < 0.05. 
SEVO = sevoflurane.
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In addition, sevoflurane exposure largely prevented CLP-
induced renal and hepatic injury.
Volatile Anesthetics in States of Tissue Inflammation
In a number of previous studies, volatile anesthetics have 
been reported to reduce systemic inflammation and organ 
damage both in animals7–12 and humans.13–16 However, the 
underlying mechanisms remain poorly understood, and it has 
not yet been systematically determined whether these effects 
could be translated into a positive effect on organ function 
and outcome in the septic murine peritonitis model.
In the current study, both early and late administration 
of sevoflurane and exposure to desflurane were shown to 
be effective at improving the overall survival of CLP mice 
and in attenuating the expression of tissue damage marker. 
In contrast, equi-MACs of isoflurane were less effective in 
improving overall survival. In agreement with our data, a 
recently published study by Lee et al.9 found early protec-
tion using isoflurane, but a 7-day survival of 0% in both 
the CLP and the CLP + isoflurane group in a comparable 
animal model. Regarding the effectiveness of volatile anes-
thetics, studies investigating effects of volatile anesthetics on 
myocardial reperfusion injury have revealed similar differ-
ences among desflurane, isoflurane, and sevoflurane, with 
isoflurane being least effective.20,21 It has been suggested that 
different mechanisms of action may be responsible for the 
observed differences in protective effects.21
Interestingly, desflurane and sevoflurane provided pro-
longed protection against murine septic peritonitis although 
both compounds have very low blood and tissue solubility. 
This indicates that the protective effects may be the result of 
triggered long-lasting modulatory reactions. Reviewing the 
literature reveals that protective action appears to be global 
in nature. Volatile anesthetics have been described to interact 
with and modulate the immune system,22 coagulation cas-
cade,23 metabolism24 or adenosine adenosine triphosphate–
sensitive potassium channels.25 They attenuate sequestration 
of organ damage markers and inflammatory mediators 
including a broad variety of chemokines and cytokines that 
play a pivotal role in the initial hyperinflammatory phase 
of sepsis. In the current study, markers of renal and hepatic 
function 24 h after CLP procedure revealed that sevoflurane 
provides significant protection and may prevent end-organ 
damage in murine sepsis. These results are consistent with 
an earlier study showing that isoflurane protects from CLP-
induced hepatic and renal injury.9 Whether prevention of 
organ damage is a primary mechanism of protection by vola-
tile anesthetics, thereby playing a pivotal role in outcome, 
rather than a mere consequence of a more controlled immune 
reaction that prevents host organs from being attacked by 
leukocytes requires further investigation. The findings are 
in good agreement with clinical studies reporting that vola-
tile anesthetics reduce ischemia–reperfusion-induced organ 
damage in patients.16 Regarding inflammation (secondary 
endpoint), CLP-induced cytokine expression in plasma 
and peritoneal fluid at 24 h after CLP was not significantly 
affected by sevoflurane. A priori power analysis based on the 
measured effect size (inflammatory mediator result from our 
experiments) reveals that more than 100 animals per group 
would be required to support the performed statistical tests 
with sufficient power.
Limitations of the Experimental Model
The current study clearly shows significant beneficial effects, 
however, requires validation in other animal models and 
insight into the mechanism of action before first conclu-
sions on the potential benefits of volatile anesthetics in septic 
peritonitis can be drawn. Particularly, larger animal numbers 
are required to consolidate the beneficial effects of volatile 
anesthetics in CLP and to identify their role on the inflam-
matory response. Regarding the translation of observations 
made in animal models of sepsis using (antiinflammatory) 
drugs, clinical trials have failed because most animal mod-
els inadequately mirror the immune response in humans.26 
Another limitation of the CLP animal model may arise 
by shifting from a true sepsis model into an intraabdomi-
nal abscess model by the formation of a walled-off abscess. 
Indeed, we observed abscess formation in survivors in the 
region of the cecum after 7 days; however, bacterial counts 
in peritoneal fluid and blood were comparable for all groups. 
Despite promising data from patients undergoing heart, liver, 
and lung surgery, only clinical studies can ultimately reveal 
the actual therapeutic benefit of sevoflurane in patients suf-
fering from conditions with complex inflammation-mediated 
pathophysiology such as sepsis.
Volatile Anesthetics in Animal Models of Sepsis and 
Inflammation
Importantly, these results reveal that anesthesia has a pivotal 
effect on the outcome of CLP mice. Thus, special caution is 
required when using volatile anesthetics during surgical pro-
cedures (e.g., CLP induction) as this may significantly affect 
outcome. Comparison of data among studies using different 
anesthesia protocols is not recommended. This may not be 
limited to CLP models in mice, but may also hold for other 
models investigating inflammation-mediated conditions.
Conclusion and Perspective
This study provides the first experimental demonstration 
that the application of both desflurane and sevoflurane 
markedly reduce CLP-induced 7-day mortality in a model 
of murine septic peritonitis. Improvement in overall survival 
with volatile anesthetics is accompanied by reduced end-
organ damage. Although the mechanism of organ protection 
by volatile anesthetics remains poorly understood, the action 
has proven to be robust in nature and therefore holds poten-
tial for translation. The use of volatile anesthetics in experi-
mental studies may have a severe consequence on outcome 
and may be a confounder becoming critical when comparing 
study data where different anesthesia protocols were used.
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